XML 50 R35.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Apr. 07, 2021
Apr. 25, 2020
May 20, 2017
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Stock-Based Compensation (Details) [Line Items]                    
Restricted stock awards, description               There were 14,723 and 5,506 unvested restricted stock awards issued totaling $83,888 and $50,000 based on a fair value of the Company’s common stock on the date of grant, as of June 30, 2021 and December 31, 2020, respectively. During the three months ended June 30, 2021 and 2020, there were 15,000 and 3,160 restricted stock awards granted during the period, respectively, and 20,225 of restricted stock awards forfeited during the three months ended June 30, 2020. The Company recognized $4,688 and $156,250 of stock based compensation for vested restricted shares during the three months ended June 30, 2021 and June 30, 2020, respectively. In addition, during the six months ended June 30, 2021 and 2020, there were 15,000 and 6,952 restricted stock awards granted during the period, respectively, and 20,225 of restricted stock awards forfeited during the six months ended June 30, 2020. The Company recognized $34,629 and $156,250 of stock based compensation for vested restricted shares during the six months ended June 30, 2021 and June 30, 2020, respectively.     
Shares of common stock outstanding, percentage       6.00%       6.00%    
Stock options to purchase common shares (in Shares)   20,225                
Stock-based compensation exercisable percentage   100.00%                
Fair market value of common stock percentage   100.00%                
Additional shares of common stock (in Shares)   3,033                
Stock-based compensation       $ 321,427 $ 369,884 $ 571,691 $ 130,990      
Stock-based compensation within general and administrative expense       302,993   571,691   $ 672,877 $ 702,681  
Stock-based compensation within research and development expense       18,433   $ 0   18,433 0  
Share based compensation expense               $ 691,310 $ 702,681  
Weighted-average grant-date fair value of stock options (in Dollars per share)               $ 3.09   $ 5.66
Stock based compensation unrecognized costs       $ 665,560       $ 665,560    
Weighted average term               2 years 2 months 26 days    
Initial Issuance Under Plan [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Aggregate number of share issued (in Shares)     303,382              
Stock Option [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Stock options to purchase common shares (in Shares)   2,022                
Black-Scholes Option Pricing Model [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Number of stock option based value   $ 25,000                
Board [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Awards of options to purchase shares of common stock (in Shares) 197,500                  
Stock option exercise price (in Dollars per share) $ 4.62                  
Grant date fair value of options $ 612,050                  
Non-Employee Directors [Member]                    
Stock-Based Compensation (Details) [Line Items]                    
Awards of options to purchase shares of common stock (in Shares) 52,922                  
Stock option exercise price (in Dollars per share) $ 4.62                  
Grant date fair value of options $ 162,156